Stay updated on PK Comparability in Healthy Males: Clinical Trial
Sign up to get notified when there's something new on the PK Comparability in Healthy Males: Clinical Trial page.

Latest updates to the PK Comparability in Healthy Males: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record now presents the Phase I pharmacokinetic comparability study of MYL-1402O and US- and EU-marketed Avastin in healthy male volunteers, including its design, eligibility criteria, outcomes, and publication information.SummaryDifference48%

- Check20 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0; the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces an NIH website transition and links to updates and FAQs, including a notice about terminology changes for artificial intelligence.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2 on the page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 on the 403 error page; no study details changed.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study record view shows a 403 Forbidden message with a Home link instead of study details.SummaryDifference0.5%

Stay in the know with updates to PK Comparability in Healthy Males: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK Comparability in Healthy Males: Clinical Trial page.